Canadian Cancer Trials Group Bulletins

General


In the News: Dr. Wendy Parulekar interview

Making a Difference through Clinical Trials

When Wendy Parulekar was first starting out as a physician and researcher, she remembers feeling uneasy about admitting that there were things she didn?\'t know.

"It was an uncomfortable space for me when I first started my career," she recalls. "But honesty and transparency are so important in our interactions with patients, that if we want to find cures, we have to articulate what we don?t know and what we want to improve."

Indeed, Parulekar says it is those questions inspired by the unknown that are at the heart of the work she does as a Senior Investigator with the Canadian Cancer Trials Group (CCTG), a research group at Queen's that brings together more than 2,000 Canadian and international investigators
overseeing as many as 30 to 40 trials at any given time.

"Any clinical trial that is conducted represents efforts on the part of a lot of people," she says. "That's why we do our best to design what we think are the best clinical trials answering the most important questions."

Read the full story in the latest addition on page 7.
http://queensu.ca/vpr/sites/webpublish.queensu.ca.vprwww/files/files/eAFFECT/17-0049%20VPR%20(e)AFFECT%20Spring%202017%20issue.pdf

Dr. Wendy Parulekar